Filing Details

Accession Number:
0001209191-23-035831
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-09 16:20:31
Reporting Period:
2023-06-08
Accepted Time:
2023-06-09 16:20:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1240122 G Michael Grey C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-08 14,608 $2.94 14,608 No 4 M Direct
Common Stock Disposition 2023-06-08 14,608 $29.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-06-08 14,608 $0.00 14,608 $2.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
345,784 2029-03-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 289,198 Indirect By The Grey Family Trust dated November 12,1999
Common Stock 93,750 Indirect By The Grey 2018 Irrevocable Children's Trust
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 30, 2022.
  2. 1/4th of the shares vest one year after November 5, 2018, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.